Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
105 Cards in this Set
- Front
- Back
Determines the duration of action of Drug.
|
Biotransformation
|
|
Main Organ of biotransformation
|
Liver
|
|
Important for orally administered drugs to be metabolized.
|
Gi tract, Upper Intestine
|
|
Participates in entero-hepatic cycling of glucoronides.
|
Liver and upper intestine
|
|
Important site for basic drugs and inhaled drugs
|
Lungs
|
|
Biotransforms dermally applied drugs
|
Skin
|
|
Helps eliminate some drugs in urine
|
Kidney
|
|
May be important for CNS active drugs
|
Brain
|
|
Age and gentic make up effect on metabolism
|
Internal ( intrinsic)
|
|
How Nutrition, Food, Disease state, other drugs effect metabolism.
|
External ( environmental )
|
|
Discovered with debrisoquine, metabolizes many N-containing drugs, 1-15 % are poor metabolizers, low doses given to those who are lacking this enzyme.
|
CYP2D6
|
|
First shown with mephenytoin, Oriental poor metabolizers have less of this enzyme.
|
CYP2C19
|
|
Low rates of conjugation of bilirubin are because lack of this enzyme.
|
UGT-1 family
|
|
Newborns have low levels of this enzyme.
|
UGT
|
|
Metabolism decreases when this number increases.
|
Age ( as you get older metabolism decreases.)
|
|
First recognized polymorphism, affects the metabolism of drugs like isoniazid.
|
NAT-2
|
|
Asian and natives have a low incidence of this.
|
Slow acetylators
|
|
Swedish have 70% and US has 50 % of this.
|
Slow acetylators
|
|
Omeprazole induces this enzyme
|
CYP1A2
|
|
Phenobarbital and Carbamezpine induce this enzyme
|
CYP2 and 3
|
|
Isoniazid induces this enzyme
|
CYP2E1
|
|
What you do with hot tea or coffee
|
CYP slowly
|
|
Rifampicin induces this enzyme
|
CYP3A4 and 5
|
|
Clofibrate induces this enzyme
|
CYP4
|
|
UGT and GST are induced by this drug
|
Phenobarbital and othe barbiturates
|
|
Oltipraz can induce this enzyme
|
GST
|
|
CYP1A2 can be induced by these
|
Tobacco, Charbroiled foods
|
|
CYP1 and 2 can be induced by these
|
PCBs and DDT
|
|
Alcohol can induce this CYP
|
2E1
|
|
St. Johns wart is an inducer of this enzyme
|
CYP3A4
|
|
Bioflavaniods and garlic and onion are weak inducers of these enzymes
|
CYP, GST
|
|
Perservatives can induce these enzymes
|
GST and UGT
|
|
Green tea and black tea can induce 3 enzymes name them
|
CYP, UGT, GST
|
|
Can down regulate CYP2 and 3 family members during viral infections
|
Interferons or cytokines
|
|
This liver disease leads to lowered levels of enzymes
|
Cirrhosis
|
|
Most variable of all CYP enzymes
|
2D6
|
|
Least variable of the CYP enzymes
|
2E1 and 3A4/5
|
|
Present in higher concentration than PAPS
|
UDP- glucoronic acid
|
|
These are usually present in high concentrations
|
GSH and NADPH and NADH
|
|
GSH level decrease when this decreases
|
Nutrition
|
|
Malnutrion of aa can lead to this
|
Reduced aa conjugation
|
|
Ethanol consumptions lowers this
|
NADPH
|
|
Indinavir and saquinavir are both substrates for this enzyme
|
CYP3A4
|
|
Inhibits CYP3A4 by binding to it
|
Erythromycin metabolites
|
|
Ketoconazole and other imiidizole containing drugs inhibit this enzyme
|
CYP
|
|
The products in Grapefuit that inhibit CYP3A4
|
Furnocoumarins and flavanoids
|
|
This is when a receptor binding causes a biological activity
|
Intrinsic activity (alpha factor)
|
|
GABA-A is this type of channel
|
Cl- gated
|
|
All glutamate receptor types
|
Cation channels
|
|
Inhibits Calcium channels
|
Go
|
|
Activates potassium channels
|
Gi
|
|
Activates Calcium channels
|
Gs
|
|
Gq activates this
|
PLC
|
|
PLC makes
|
IP3 and DAG
|
|
Gq uses this for of energy to activate this
|
GDP becomes GTP to activate PLC
|
|
IP3 frees this cation
|
Calcium
|
|
Calcium activates this
|
Protein Kinases
|
|
DAG activates this
|
PKC
|
|
Activates AC to increase cAMP
|
Gs
|
|
Does the opposite of Gs
|
Gi
|
|
Gs uses this ase energy form to activate AC
|
GTP
|
|
cAMP is inactivated by this (Viagra)
|
Phosphodiesterases
|
|
PKA is activated by cAMP when this energy form is used
|
ATP
|
|
Is activated by Gi to make PG
|
PLA2
|
|
When proteins are modified by this they do things
|
Phosphorylation
|
|
Decreases the chance of an AP, and is located on the dendrites or cell bodies.
|
Impulse modulating autoreceptors
|
|
Autoreceptor located on presynaptic terminals and inhibits NT syn
|
Synthesis modulating autoreceptor
|
|
Autoreceptor located on presynaptic terminals inhibits NT release
|
Release modulating autoreceptors
|
|
What the body does to the drugs (ADME)
|
Pharmacokinetic
|
|
What the body does to the drug (DDC)
|
Pharmacodynamics
|
|
Means Poison or Drug
|
Pharmakon
|
|
Drugs for different folks
|
Pharmacogenomics
|
|
Adverse effects of chemical compounds. Includes environmental exposure.
|
Toxicology
|
|
This act required that safety testing and labels be accurate and complete
|
1938: Federal Food, Drug and Cosmetic Act
|
|
Amendment responsible for the "Caution: Federal law prohibits dispensing without prescription" on Rx bottles
|
1951: Durham-Humphrey
|
|
Kefhauver-Harris Amendment: Required testing for both safety and effectiveness for new drugs and ones between1938 and _____
|
1962
|
|
Drugs come from different sources this is the main source
|
Plant or Animals
|
|
Most drugs are used to
|
Treat symptoms
|
|
13000
|
RX drugs available
|
|
2-3 weeks
|
New drug approved
|
|
Most of the times people see doctors they get this
|
RX
|
|
Old people take this
|
25% of RX
|
|
Ptenet life for a drug in US
|
20 years
|
|
To do clinical trials you submit this to fda
|
IND
|
|
When you submit NDA to FDA it takes this long for them to approve
|
20-24 months
|
|
CAST looked at
|
PVC-premature ventricular contractions
|
|
Rezulin taken of market because
|
Heart and Liver failures
|
|
Vioxx pulled of market for this
|
Increased risk of MI or Heart problems
|
|
Not approved for use by FDA
|
Combo of Phen-Fen
|
|
Full agonist
Alpha = ? |
alpha = 1
|
|
Partial agonist
Alpha = ? |
0 < alpha < 1
|
|
Antagonist
Alpha = ? |
alpha = 0
|
|
Full agonist elicits?
|
Emax at Bmax
|
|
Partial agonist never elicits?
|
Emax
|
|
Noncompetitive shifts?
|
Emax downward
NO effect on EC50 or slope |
|
Competitive shifts?
|
EC50 to the right
NO effect on Emax or slope |
|
Inverse agonist
Alpha = ? |
-1 < alpha < 0
|
|
Inverse agonist can resemble?
|
Antagonist
|
|
Bmax =?
|
Max number of binding sites in tissue sample
|
|
Bmax found when?
|
Drug concentration has saturated the receptors
|
|
Bmax measures?
|
Occupancy
NOT activity |
|
Kd =?
|
Drug concentration occupies half of Bmax
|
|
2 things that can change Kd?
|
Structural specificity
Stereoselectivity |
|
Hill Plot: ?
|
Determines if dose response or binding curve has a normal slope
|
|
Hill plot is a ?
|
linear version of log-dose graph
|